Jerome Alan Grant Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
Jerome Alan Grant has an estimated net worth of at least $14.6 million*, as of Oct. 29, 2025. They own 430,215 shares of UTI stock. They have sold 229,532 shares of UTI stock since 2021, for an estimated $3.5 million.
Jerome Alan Grant $UTI SEC Form 4 Insider Trading
Jerome Alan Grant has filed a total of 5 insider trades in $UTI since 2021. Their most recent trade was a sale of 60,040 shares, made on Feb 27, 2026. Their largest trade was a sale of 68,000 shares, made on Aug 23, 2024. We estimate that they now own 430,215 shares of $UTI, worth an estimated $11.1 million.
Insider Trading at $UTI
There have been a total of 57 insider trades reported at $UTI since 2021, with 2.2 million shares purchased and 11.2 million shares sold. The most active insider traders in $UTI stock have been Sherrell Smith, Jerome Alan Grant, and Christopher E. Kevane. The most recent trade was a sale of 60,040 shares reported by Jerome Alan Grant (Chief Executive Officer), made on Feb 27, 2026.
History of Insider Stock Trades by Jerome Alan Grant
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
UTI
|
Sale | 60,040 | Feb 27, 2026 | March 2, 2026, 8:45 p.m. |
|
UTI
|
Sale | 56,492 | May 12, 2025 | May 14, 2025, 5 p.m. |
|
UTI
|
Sale | 68,000 | Aug 23, 2024 | Aug. 23, 2024, 8:54 p.m. |
|
UTI
|
Sale | 20,000 | May 31, 2022 | June 1, 2022, 8 p.m. |
|
UTI
|
Sale | 25,000 | Jun 01, 2022 | June 1, 2022, 8 p.m. |
$UTI Executives and Stock Owners with Insider Trades
-
Sherrell Smith, EVP, Chief Academic Officer
-
Jerome Alan Grant, Chief Executive Officer
-
Christopher E. Kevane, EVP and Chief Legal Officer
-
Todd A Hitchcock, EVP/COO
-
Carolyn Ann Frank, SVP/Chief HR Officer
-
Troy R Anderson, EVP and CFO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.